Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) EPS (Weighted Average and Diluted): 2020-2023

Historic EPS (Weighted Average and Diluted) for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to -$0.52.

  • Immuneering's EPS (Weighted Average and Diluted) fell 4.00% to -$0.52 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.89, marking a year-over-year increase of 1.56%. This contributed to the annual value of -$1.88 for FY2023, which is 1.57% up from last year.
  • Immuneering's EPS (Weighted Average and Diluted) amounted to -$0.52 in Q4 2023, which was down 20.93% from -$0.43 recorded in Q3 2023.
  • Over the past 5 years, Immuneering's EPS (Weighted Average and Diluted) peaked at -$0.05 during Q4 2021, and registered a low of -$1.61 during Q2 2021.
  • Over the past 3 years, Immuneering's median EPS (Weighted Average and Diluted) value was -$0.49 (recorded in 2022), while the average stood at -$0.60.
  • Per our database at Business Quant, Immuneering's EPS (Weighted Average and Diluted) soared by 95.76% in 2021 and then crashed by 900.00% in 2022.
  • Over the past 4 years, Immuneering's EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.18 in 2020, then surged by 95.76% to -$0.05 in 2021, then slumped by 900.00% to -$0.50 in 2022, then decreased by 4.00% to -$0.52 in 2023.
  • Its last three reported values are -$0.52 in Q4 2023, -$0.43 for Q3 2023, and -$0.43 during Q2 2023.